You may be eligible to participate in the CONTROL-RA study if you:
- Are between the ages of 18 and 75
- Have been diagnosed with moderate to severe rheumatoid arthritis
- Are currently taking etanercept (Enbrel®), adalimumab (Humira®) or their respective biosimilars
- Are willing to consider changes to your rheumatoid arthritis treatment